2007-08 News Releases
May 8, 2008
Wellmune WGP® Receives Regulatory Approval in Australia
May 7, 2008
Robert P. Hill Joins Biothera Board of Directors
April 9, 2008
Wellmune Alleviates Severity and ‘Down Time' Due to Cold Symptoms
March 19, 2008
Biothera Compounds Induce Immune Responses via Different Mechanisms
March 19, 2008
Biothera Responds to Patent Litigation Statements
March 10, 2008
Biothera Awarded Patent for New Cancer Therapy
February 28, 2008
Biothera Drug Synergistic with Avastin Against Cancer, Study Finds
December 7, 2007
Benson Named 'Rising Star' Among Minnesota Lawyers
November 6, 2007
Wellmune WGP® Reduces Incidence of Stress-Related Health Challenges
November 6, 2007
Wellmune WGP® Reduced Fatigue and Infection Symptoms in Marathoners
October 9, 2007
Biothera initiates Phase Ib/IIa clinical trial in cancer patients
October 5, 2007
Biothera Recognized as One of Minnesota’s Top Technology Companies
September 11, 2007
Imprime PGG Increases Efficacy of Erbitux Against Non-Small Cell Lung Cancer
July 29, 2007
Wellmune WGP® Receives 2007 IFT Food Expo Innovation Award
July 27, 2007
Biothera and MIT File Patent Infringement Lawsuit Against Biorgin
July 26, 2007
Biothera to Introduce Wellmune WGP® at IFT Food Expo
June 4, 2007
Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
May 4, 2007
Biothera to Present at BIO International Convention
May 1 , 2007
Biothera Compounds Enhance Human Immune Cell Function, Study Finds
April 20, 2007
Biothera Achieves ‘Good Laboratory Practice’ Status
March 6 , 2007
Vasilakos Joins Biothera as Vice President, Immunology
